| Description | This product is derived from a human antibody that recognizes myeloid-derived growth factor (MYDGF). MYDGF is a paracrine-acting protein produced by bone marrow-derived monocytes and macrophages that protects and repairs the heart after myocardial infarction (MI). This effect could be used to develop protein-based therapies for ischemic tissue repair, beyond application only to cardiac tissue. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Human |
| Isotype | Human IgG |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | Neut |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
